Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor and/or Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07227571
What this trial is testing

Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial

Who this might be right for
Advanced OsteosarcomaRecurrent OsteosarcomaRefractory Osteosarcoma
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT03838744
What this trial is testing

Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments.

Who this might be right for
Advanced Soft Tissue Sarcoma
Italian Sarcoma Group 130
Testing effectiveness (Phase 2)Study completedNCT02992912
What this trial is testing

Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours

Who this might be right for
Patients With Metastatic Tumours (Colorectal Cancer, Non-small Lung Cancer, Renal Cell Carcinoma or Sarcoma )
Gustave Roussy, Cancer Campus, Grand Paris 138
Testing effectiveness (Phase 2)Study completedNCT02632448
What this trial is testing

LY2880070 in Participants With Advanced or Metastatic Cancer

Who this might be right for
Solid TumorsColorectal CancerBreast Cancer+9 more
Esperas Pharma Inc. 229
Testing effectiveness (Phase 2)WithdrawnNCT02229981
What this trial is testing

Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma

Who this might be right for
Diffuse Large B Cell LymphomaKaposi Sarcoma
RedHill Biopharma Limited
Early research (Phase 1)Study completedNCT00634504
What this trial is testing

Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze

Who this might be right for
OsteosarcomaLeukemiaLymphoma
BTG International Inc. 20
Not applicableStudy completedNCT00433407
What this trial is testing

T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

Who this might be right for
Breast CancerLung CancerOvarian Cancer+3 more
Jonsson Comprehensive Cancer Center 12
Not applicableLooking for participantsNCT07727434
What this trial is testing

Stress and Anxiety Before Biopsy, After Biopsy Results, and During Treatment in Patients With Suspected Bone or Soft Tissue Cancer

Who this might be right for
Bone NeoplasmsSoft Tissue NeoplasmsAnxiety+1 more
Istanbul University 100
Testing effectiveness (Phase 2)Study completedNCT01962103
What this trial is testing

Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors

Who this might be right for
NeuroblastomaRhabdomyosarcomaEwing's Sarcoma+20 more
Celgene 107
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT01209598
What this trial is testing

PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma

Who this might be right for
SarcomaLiposarcoma
Memorial Sloan Kettering Cancer Center 90
Not applicableStudy completedNCT01430637
What this trial is testing

Studying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1

Who this might be right for
Sarcoma
Children's Oncology Group 20
Testing effectiveness (Phase 2)Study completedNCT00484341
What this trial is testing

Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.

Who this might be right for
Metastatic Adult Soft Tissue Sarcoma
AGC Biologics S.p.A. 69
Testing effectiveness (Phase 2)Study completedNCT00194766
What this trial is testing

Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer

Who this might be right for
Breast CancerSoft Tissue Sarcoma
University of Washington 35
Early research (Phase 1)Ended earlyNCT05429502
What this trial is testing

Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors

Who this might be right for
Neuroblastoma
Novartis Pharmaceuticals 12
Testing effectiveness (Phase 2)Ended earlyNCT02575066
What this trial is testing

Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients

Who this might be right for
SarcomaSoft Tissue Sarcomas
The Netherlands Cancer Institute 25
Testing effectiveness (Phase 2)Ended earlyNCT00717522
What this trial is testing

Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Celgene 7
Not applicableUnknownNCT03375437
What this trial is testing

RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.

Who this might be right for
Soft Tissue SarcomaAdvanced CancerMetastatic Cancer
Centre Leon Berard 376
Testing effectiveness (Phase 2)Study completedNCT00965172
What this trial is testing

Caphosol in Sarcoma Patients With Mucositis

Who this might be right for
SarcomaOral Mucositis
M.D. Anderson Cancer Center 30
Early research (Phase 1)Ended earlyNCT04544995
What this trial is testing

Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)

Who this might be right for
Neoplasms
GlaxoSmithKline 47
Next Page